David Kombo
Principal Scientist II Sanofi
David Kombo is Principal Scientist II at Sanofi, where he drives AI/ML-guided drug design and computational chemistry efforts. He holds a BSc in Chemistry from the University of Kinshasa and a PhD in Biomedical Sciences (molecular biophysics & biochemistry) from the Icahn School of Medicine at Mount Sinai. After postdoctoral work in molecular dynamics, he held computational roles in biotech before joining Sanofi in 2020.
Seminars
Friday 20th March 2026
Generating AI Strategies for the Enhancement of Hit Finding & Optimization
3:00 pm
- Virtual screening strategies for ultra-large databases
- Predictive AI/ML models for potency at the target and ADME-Tox profiling
- Property-based drug design coupled with AI/ML models, chemical space network analysis and composite metrics important in lead optimization
